Natural Product ID: | NPC263507 |
Common Name: | Cryptophycin A |
IUPAC Name: | (3S,6R,10R,13E,16S)-10-[(3-chloro-4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-[(1S)-1-[(2R,3R)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone |
Synonyms: | |
Molecular Formula: | C35H43ClN2O8 |
Standard InCHIKey: | PSNOPSMXOBPNNV-VVCTWANISA-N |
Standard InCHI: | InChI=1S/C35H43ClN2O8/c1-20(2)16-29-35(42)44-27(22(4)31-32(46-31)24-10-7-6-8-11-24)12-9-13-30(39)38-26(33(40)37-19-21(3)34(41)45-29)18-23-14-15-28(43-5)25(36)17-23/h6-11,13-15,17,20-22,26-27,29,31-32H,12,16,18-19H2,1-5H3,(H,37,40)(H,38,39)/b13-9+/t21-,22+,26-,27+,29+,31-,32-/m1/s1 |
Canonical SMILES: | COc1ccc(cc1Cl)C[C@H]1N=C(O)/C=C/C[C@H](OC(=O)[C@@H](OC(=O)[C@@H](CN=C1O)C)CC(C)C)[C@@H]([C@H]1O[C@@H]1c1ccccc1)C |
First Find Year: | |
Max Developmental Stage: | |
Synthetic Gene Cluster: | BGC0000975 ; |
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO10879 | Lasius meridionalis | Species | Formicidae | Eukaryota | UNPD* | |||
NPO12744 | Ajuga nipponensis | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO1537 | Vaccinium arctostaphylos | Species | Ericaceae | Eukaryota | UNPD* | |||
NPO18618 | Neurolaena lobata | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO19541 | Smilax moranensis | Species | Smilacaceae | Eukaryota | UNPD* | |||
NPO1969 | Streptomyces pilosus | Species | Streptomycetaceae | Bacteria | UNPD* | |||
NPO19804 | Lycopodium saururus | Species | Lycopodiaceae | Eukaryota | UNPD* | |||
NPO23436 | Cladrastis sikokiana | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO28833 | Eleutherococcus sieboldianus | Species | Araliaceae | Eukaryota | UNPD* | |||
NPO3613 | Eriobotrya deflexa | Species | Rosaceae | Eukaryota | UNPD* |
Activity Type | # Activity |
---|---|
ED50 | 5 |
IC50 | 18 |
Activity Type | # Activity |
---|---|
Cell Line | 18 |
Individual Protein | 1 |
Organism | 1 |
Others | 2 |
Protein Complex | 1 |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT114 | Cell Line | LoVo | Homo sapiens | IC50 | = | 0.0092 | nM | 9090872 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 0.002 | nM | 10.1016/0960-894X(96)00182-5 |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | IC50 | = | 0.0092 | nM | 9090872 |
NPT2 | Others | Unspecified | ED50 | = | 1.00E-06 | nM | 9873466 | |
NPT2 | Others | Unspecified | IC50 | = | 3400 | nM | 15214797 | |
NPT3027 | Cell Line | MCF7S | Homo sapiens | IC50 | = | 0.003 | nM | 12639575 |
NPT319 | Cell Line | B16 | Mus musculus | ED50 | = | 1.3 | nM | 9873466 |
NPT319 | Cell Line | B16 | Mus musculus | IC50 | = | 0.03 | nM | 10.1016/0960-894X(96)00182-5 |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | ED50 | = | 0.018 | nM | 14736249 |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | IC50 | = | 0.013 | nM | 12639575 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
● The left chart: Distribution of similarity level between NPC263507 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.56 or Top200).
range | Tanimoto Coefficient |
---|---|
0-0.1 | 158 |
0.1-0.2 | 884 |
0.2-0.3 | 2970 |
0.3-0.4 | 8893 |
0.4-0.5 | 4736 |
0.5-0.6 | 12106 |
0.6-0.7 | 1100 |
0.7-0.8 | 31 |
0.8-0.85 | 0 |
0.85-0.9 | 1 |
0.9-0.95 | 3 |
0.95-1 | 7 |
Similarity Score | Similarity Level | Natural Product ID |
---|
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
● The left chart: Distribution of similarity level between NPC263507 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range | Tanimoto Coefficient |
---|---|
0-0.1 | 123 |
0.1-0.2 | 543 |
0.2-0.3 | 1004 |
0.3-0.4 | 2149 |
0.4-0.5 | 2651 |
0.5-0.6 | 2191 |
0.6-0.7 | 478 |
0.7-0.8 | 20 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 2 |
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6307 | Remote Similarity | NPD3052 | Approved |
0.6307 | Remote Similarity | NPD4579 | Clinical (unspecified phase) |
0.631 | Remote Similarity | NPD7495 | Discontinued |
0.631 | Remote Similarity | NPD3812 | Clinical (unspecified phase) |
0.6313 | Remote Similarity | NPD3655 | Clinical (unspecified phase) |
PubChem CID | 6438401 |
ChEMBL | CHEMBL441018 |
ZINC |
Molecular Weight: | 654.27 |
ALogP: | 1.4508 |
MLogP: | 4.1 |
XLogP: | 7.185 |
# Rotatable Bonds: | 16 |
Polar Surface Area: | 139.54 |
# H-Bond Aceptor: | 9 |
# H-Bond Donor: | 2 |
# Rings: | 4 |
# Heavy Atoms: | 46 |